The tetracycline resistome is shaped by selection for specific resistance mechanisms by each antibiotic generation
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
The history of clinical resistance to tetracycline antibiotics is characterized by cycles whereby the deployment of a new generation of drug molecules is quickly followed by the discovery of a new mechanism of resistance. This suggests mechanism-specific selection by each tetracycline generation; however, the evolutionary dynamics of this remain unclear. Here, we evaluate 24 recombinant Escherichia coli strains expressing tetracycline resistance genes from each mechanism (efflux pumps, ribosomal protection proteins, and enzymatic inactivation) in the context of each tetracycline generation. We employ a high-throughput barcode sequencing protocol that can discriminate between strains in mixed culture and quantify their relative abundances. We find that each mechanism is preferentially selected for by specific antibiotic generations, leading to their expansion. Remarkably, the minimum inhibitory concentration associated with individual genes is secondary to resistance mechanism for inter-mechanism relative fitness, but it does explain intra-mechanism relative fitness. These patterns match the history of clinical deployment of tetracycline drugs and resistance discovery in pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, ribosomal protection proteins, such as those encoded by tet(M) and tet(O), allow bacteria to continue translating proteins despite the presence of tetracyclines by preventing the drug from binding effectively to the ribosome [256,257,258].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [256]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biopython: freely available python tools for computational molecular biology and bioinformatics
Cock, P. J. A., Antao, T., Chang, J. T., Chapman, B. A., Cox, C. J., Dalke, A., Friedberg, I., Hamelryck, T., Kauff, F., Wilczynski, B., et al. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp163 · Cited by 6,080 · cited 2×
“Protein sequences from each resistant gene with ≥ 99% sequence identity were retrieved from the NCBI database using Blastp and Biopython 96 .”
Antibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Chopra, I., & Roberts, M. (2001) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.65.2.232-260.2001 · Cited by 4,517
Antibiotic resistance is ancient
D’Costa, V. M., King, C. E., Kalan, L., Morar, M., Sung, W. W. L., Schwarz, C., Froese, D., Zazula, G., Calmels, F., Debruyne, R., et al. (2011) · Nature · doi:10.1038/nature10388 · Cited by 2,720
Update on acquired tetracycline resistance genes
Roberts, M. C. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.02.034 · Cited by 1,010
Brodersen, D. E., Clemons, W. M., Carter, A. P., Morgan-Warren, R. J., Wimberly, B. T., & Ramakrishnan, V. (2000) · Cell · doi:10.1016/s0092-8674(00)00216-6 · Cited by 950 · cited 1×
“These drugs inhibit bacterial protein synthesis by binding to the 16S rRNA of the 30S ribosome subunit, preventing accommodation of incoming aminoacyl-tRNAs 17 .”
Functional characterization of the antibiotic resistance reservoir in the human microflora
Sommer, M. O. A., Dantas, G., & Church, G. M. (2009) · Science · doi:10.1126/science.1176950 · Cited by 878
Self-citationHorizontal gene transfer and adaptive evolution in bacteria.
Arnold, B. J., Huang, I.-T., & Hanage, W. P. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00650-4 · Cited by 869 · cited 1×
“Antibiotic resistance in bacteria is an extreme example of this trade-off, as bacterial cells lacking resistance during antibiotic exposure suffer immediate consequences (i.e., inhibited growth or cell death), but can acquire and eject antibiotic resistance genes with relative ease 3,4 .”
Roberts, M. C. (1996) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.1996.tb00251.x · Cited by 689 · cited 4×
“This is consistent with the history of the clinical tetracycline resistome 30 , as well as the development strategies for each generation of antibiotic to counter the mechanism(s) conferring resistance to the previous generation 21 .”
InfluentialRibosomal Protection Proteins and Their Mechanism ofTetracyclineResistance
Connell, S. R., Tracz, D. M., Nierhaus, K. H., & Taylor, D. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3675-3681.2003 · Cited by 449 · cited 1×
“RPPs are translational GTPases with homology to the elongation factor EF-G 40 .”
Research works printed but not linked: 89
- Orr, H. A. Fitness and its role in evolutionary genetics. Nat. Rev. Genet. 10, 531–539 (2009). · DOI · Paper page
- Kassen, R. & Rainey, P. B. The ecology and genetics of microbial diversity. Annu. Rev. Microbiol. 58, 207–231 (2004). · DOI · Paper page
- Brito, I. L. Examining horizontal gene transfer in microbial communities. Nat. Rev. Microbiol. 19, 442–453 (2021). · DOI · Paper page
- Cassini, A. et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect. Dis. 19, 56–66 (2019). · DOI · Paper page
- Baym, M. et al. Spatiotemporal microbial evolution on antibiotic landscapes. Science 353, 1147–1151 (2016). · DOI · Paper page
- Palmer, A. C., Angelino, E. & Kishony, R. Chemical decay of an antibiotic inverts selection for resistance. Nat. Chem. Biol. 6, 105–107 (2010). · DOI · Paper page
- Lazar, V. et al. Bacterial evolution of antibiotic hypersensitivity. Mol. Syst. Biol. 9, 700 (2013). · DOI · Paper page
- Boolchandani, M., D’Souza, A. W. & Dantas, G. Sequencing-based methods and resources to study antimicrobial resistance. Nat. Rev. Genet. 20, 356–370 (2019).
- Walsh, C. Molecular mechanisms that confer antibacterial drug resistance. Nature 406, 775–781 (2000). · DOI · Paper page
- Andersson, D. I. & Hughes, D. Antibiotic resistance and its cost: is it possible to reverse resistance? Nat. Rev. Microbiol. 8, 260–271 (2010). · DOI · Paper page
- Wright, P. M., Seiple, I. B. & Myers, A. G. The evolving role of chemical synthesis in antibacterial drug discovery. Angew. Chem. Int. Ed. Engl. 53, 8840–8869 (2014). · DOI · Paper page
- Thaker, M., Spanogiannopoulos, P. & Wright, G. D. The tetracycline resistome. Cell Mol. Life Sci. 67, 419–431 (2010). · DOI · Paper page
- Jaroszewski, J., Mamun, N. & Czaja, K. Bidirectional interaction between tetracyclines and gut microbiome. Antibiotics 12, 1438 (2023). · DOI
- Duggar, B. M. Aureomycin; a product of the continuing search for new antibiotics. Ann. N. Y Acad. Sci. 51, 177–181 (1948). · DOI · Paper page
- Finlay, A. C. et al. Terramycin, a new antibiotic. Science 111, 85 (1950). · doi:10.1126/science.111.2874.85.a
- Markley, J. L. & Wencewicz, T. A. Tetracycline-inactivating enzymes. Front. Microbiol. 9, 1058 (2018). · DOI · Paper page
- Nelson, M. L. & Levy, S. B. The history of the tetracyclines. Ann. N. Y Acad. Sci. 1241, 17–32 (2011). · DOI · Paper page
- Greer, N. D. Tigecycline (Tygacil): the first in the glycylcycline class of antibiotics. Proc. (Bayl. Univ. Med Cent.) 19, 155–161 (2006).
- Arenz, S., Nguyen, F., Beckmann, R. & Wilson, D. N. Cryo-EM structure of the tetracycline resistance protein TetM in complex with a translating ribosome at 3.9-A resolution. Proc. Natl Acad. Sci. USA 112, 5401–5406 (2015). · DOI · Paper page
- Fang, L. X. et al. Emerging high-level tigecycline resistance: novel tetracycline destructases spread via the mobile tet(X). Bioessays 42, e2000014 (2020). · DOI · Paper page
- Seifert, H., Blondeau, J. & Dowzicky, M. J. In vitro activity of tigecycline and comparators (2014-2016) among key WHO ‘priority pathogens’ and longitudinal assessment (2004-2016) of antimicrobial resistance: a report from the T.E.S.T. study. Int. J. Antimicrob. Agents 52, 474–484 (2018). · DOI
- Shakil, S., Akram, M. & Khan, A. U. Tigecycline: a critical update. J. Chemother. 20, 411–419 (2008). · DOI
- Deeks, E. D. Sarecycline: first global approval. Drugs 79, 325–329 (2019). · DOI · Paper page
- Watanabe, T. Infective heredity of multiple drug resistance in bacteria. Bacteriol. Rev. 27, 87–115 (1963). · DOI · Paper page
- Akiba, T., Koyama, K., Ishiki, Y., Kimura, S. & Fukushima, T. On the mechanism of the development of multiple-drug-resistant clones of Shigella. Jpn J. Microbiol. 4, 219–227 (1960). · DOI · Paper page
- Wasteson, Y., Hoie, S. & Roberts, M. C. Characterization of antibiotic resistance in Streptococcus suis. Vet. Microbiol. 41, 41–49 (1994). · DOI
- Paulsen, I. T., Brown, M. H. & Skurray, R. A. Proton-dependent multidrug efflux systems. Microbiol. Rev. 60, 575–608 (1996). · doi:10.1128/mr.60.4.575-608.1996 · Paper page
- Kuck, N. A. & Forbes, M. Uptake of minocycline and tetracycline by tetracycline-susceptible and -resistant bacteria. Antimicrob. Agents Chemother. 3, 662–664 (1973). · DOI
- Richter, M. F. et al. Predictive compound accumulation rules yield a broad-spectrum antibiotic. Nature 545, 299–304 (2017). · DOI · Paper page
- Burdett, V. Identification of tetracycline-resistant R-plasmids in Streptococcus agalactiae (group B). Antimicrob. Agents Chemother. 18, 753–760 (1980). · DOI · Paper page
- Burdett, V., Inamine, J. & Rajagopalan, S. Heterogeneity of tetracycline resistance determinants in Streptococcus. J. Bacteriol. 149, 995–1004 (1982). · DOI · Paper page
- Speer, B. S. & Salyers, A. A. Characterization of a novel tetracycline resistance that functions only in aerobically grown Escherichia coli. J. Bacteriol. 170, 1423–1429 (1988). · DOI
- Speer, B. S., Bedzyk, L. & Salyers, A. A. Evidence that a novel tetracycline resistance gene found on two Bacteroides transposons encodes an NADP-requiring oxidoreductase. J. Bacteriol. 173, 176–183 (1991). · DOI · Paper page
- Leski, T. A. et al. Multidrug-resistant tet(X)-containing hospital isolates in Sierra Leone. Int. J. Antimicrob. Agents 42, 83–86 (2013). · doi:10.1016/j.ijantimicag.2013.04.014
- Forsberg, K. J., Patel, S., Wencewicz, T. A. & Dantas, G. The tetracycline destructases: a novel family of tetracycline-inactivating enzymes. Chem. Biol. 22, 888–897 (2015). · DOI · Paper page
- Park, J. et al. Plasticity, dynamics, and inhibition of emerging tetracycline resistance enzymes. Nat. Chem. Biol. 13, 730–736 (2017). · DOI
- Nguyen, F. et al. Tetracycline antibiotics and resistance mechanisms. Biol. Chem. 395, 559–575 (2014). · DOI · Paper page
- Ogunmolu, O., Liu, X., Gans, N. & Wiersma, R. D. Mechanism and model of a soft robot for head stabilization in cancer radiation therapy. IEEE Int. Conf. Robot. Autom. 2020, 4609–4615 (2020).
- Li, R. et al. Co-occurrence of two tet(X) variants in an Empedobacter brevis of shrimp origin. Antimicrob. Agents Chemother. 63, e01636–19 (2019). · doi:10.1128/aac.01636-19
- Wang, L. et al. Novel plasmid-mediated tet(X5) gene conferring resistance to tigecycline, eravacycline, and omadacycline in a clinical Acinetobacter baumannii isolate. Antimicrob. Agents Chemother. 64, e01326–19 (2019). · DOI · Paper page
- Chen, C. et al. Genetic diversity and characteristics of high-level tigecycline resistance Tet(X) in Acinetobacter species. Genome Med. 12, 111 (2020). · DOI
- He, D. et al. A novel tigecycline resistance gene, tet(X6), on an SXT/R391 integrative and conjugative element in a Proteus genomospecies 6 isolate of retail meat origin. J. Antimicrob. Chemother. 75, 1159–1164 (2020). · DOI
- Liu, D. et al. Identification of the novel tigecycline resistance gene tet(X6) and its variants in Myroides, Acinetobacter and Proteus of food animal origin. J. Antimicrob. Chemother. 75, 1428–1431 (2020). · doi:10.1093/jac/dkaa037
- Gasparrini, A. J. et al. Tetracycline-inactivating enzymes from environmental, human commensal, and pathogenic bacteria cause broad-spectrum tetracycline resistance. Commun. Biol. 3, 241 (2020). · DOI · Paper page
- Berglund, F. et al. Comprehensive screening of genomic and metagenomic data reveals a large diversity of tetracycline resistance genes. Micro. Genom. 6, mgen000455 (2020).
- Blake, K. S. et al. Sequence-structure-function characterization of the emerging tetracycline destructase family of antibiotic resistance enzymes. Commun. Biol. 7, 336 (2024). · DOI
- Knapp, C. W., Dolfing, J., Ehlert, P. A. & Graham, D. W. Evidence of increasing antibiotic resistance gene abundances in archived soils since 1940. Environ. Sci. Technol. 44, 580–587 (2010). · DOI · Paper page
- Bryan, A., Shapir, N. & Sadowsky, M. J. Frequency and distribution of tetracycline resistance genes in genetically diverse, nonselected, and nonclinical Escherichia coli strains isolated from diverse human and animal sources. Appl. Environ. Microbiol. 70, 2503–2507 (2004). · DOI · Paper page
- He, T. et al. Emergence of plasmid-mediated high-level tigecycline resistance genes in animals and humans. Nat. Microbiol. 4, 1450–1456 (2019). · DOI · Paper page
- Crook, N., Ferreiro, A., Condiotte, Z. & Dantas, G. Transcript barcoding illuminates the expression level of synthetic constructs in E. coli Nissle residing in the mammalian gut. ACS Synth. Biol. 9, 1010–1021 (2020). · DOI
- Tang, H., Liu, Z., Hu, B. & Zhu, L. D-Ring modifications of tetracyclines determine their ability to induce resistance genes in the environment. Environ. Sci. Technol. 58, 1338–1348 (2024). · DOI
- Da Cunha, V. et al. Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline. Nat. Commun. 5, 4544 (2014). · DOI · Paper page
- Chen, T. et al. The tigecycline resistance gene tetX has an expensive fitness cost based on increased outer membrane permeability and metabolic burden in Escherichia coli. J. Hazard Mater. 458, 131889 (2023). · DOI
- Palmer, A. C. & Kishony, R. Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance. Nat. Rev. Genet. 14, 243–248 (2013). · DOI · Paper page
- Chait, R., Vetsigian, K. & Kishony, R. What counters antibiotic resistance in nature? Nat. Chem. Biol. 8, 2–5 (2011). · DOI
- Kelsic, E. D., Zhao, J., Vetsigian, K. & Kishony, R. Counteraction of antibiotic production and degradation stabilizes microbial communities. Nature 521, 516–519 (2015). · DOI · Paper page
- Sun, J. et al. Plasmid-encoded tet(X) genes that confer high-level tigecycline resistance in Escherichia coli. Nat. Microbiol 4, 1457–1464 (2019). · DOI · Paper page
- Shales, S. W., Chopra, I. & Ball, P. R. Evidence for more than one mechanism of plasmid-determined tetracycline resistance in Escherichia coli. J. Gen. Microbiol. 121, 221–229 (1980).
- Bjorkman, J., Nagaev, I., Berg, O. G., Hughes, D. & Andersson, D. I. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 287, 1479–1482 (2000). · DOI · Paper page
- zur Wiesch, P. A., Kouyos, R., Engelstadter, J., Regoes, R. R. & Bonhoeffer, S. Population biological principles of drug-resistance evolution in infectious diseases. Lancet Infect. Dis. 11, 236–247 (2011). · DOI · Paper page
- Jiang, L., Cai, W., Tang, F., Wang, Z. & Liu, Y. Characterization of fitness cost caused by tigecycline-resistance gene tet(X6) in different host bacteria. Antibiotics 10, 1172 (2021). · DOI
- Tang, F., Cai, W., Jiang, L., Wang, Z. & Liu, Y. Large-scale analysis of fitness cost of tet(X4)-positive plasmids in Escherichia coli. Front. Cell Infect. Microbiol. 12, 798802 (2022). · doi:10.3389/fcimb.2022.798802
- Herren, C. M. & Baym, M. Decreased thermal niche breadth as a trade-off of antibiotic resistance. ISME J. 16, 1843–1852 (2022). · DOI
- Mueller, E. A., Egan, A. J., Breukink, E., Vollmer, W. & Levin, P. A. Plasticity of Escherichia coli cell wall metabolism promotes fitness and antibiotic resistance across environmental conditions. Elife 8, e40754 (2019). · DOI
- Saenger, W., Orth, P., Kisker, C., Hillen, W. & Hinrichs, W. The tetracycline repressor-A paradigm for a biological switch. Angew. Chem. Int Ed. Engl. 39, 2042–2052 (2000). · DOI · Paper page
- Orth, P., Schnappinger, D., Hillen, W., Saenger, W. & Hinrichs, W. Structural basis of gene regulation by the tetracycline inducible Tet repressor-operator system. Nat. Struct. Biol. 7, 215–219 (2000). · DOI
- Stone, L. K. et al. Compounds that select against the tetracycline-resistance efflux pump. Nat. Chem. Biol. 12, 902–904 (2016). · DOI · Paper page
- Williford, E. E. et al. Structure-based design of bisubstrate tetracycline destructase inhibitors that block flavin redox cycling. J. Med. Chem. 66, 3917–3933 (2023). · DOI
- Markley, J. L. et al. Semisynthetic analogues of anhydrotetracycline as inhibitors of tetracycline destructase enzymes. ACS Infect. Dis. 5, 618–633 (2019). · DOI
- Bradford, P. A. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14, 933–951 (2001). · DOI · Paper page
- Bush, K. Past and Present Perspectives on beta-Lactamases. Antimicrob. Agents Chemother. 62, e01076–18 (2018). · DOI · Paper page
- Rice, L. B. Mechanisms of resistance and clinical relevance of resistance to beta-lactams, glycopeptides, and fluoroquinolones. Mayo Clin. Proc. 87, 198–208 (2012). · DOI · Paper page
- Palzkill, T. Structural and mechanistic basis for extended-spectrum drug-resistance mutations in altering the specificity of TEM, CTX-M, and KPC beta-lactamases. Front Mol. Biosci. 5, 16 (2018). · DOI · Paper page
- Marciano, D. C., Karkouti, O. Y. & Palzkill, T. A fitness cost associated with the antibiotic resistance enzyme SME-1 beta-lactamase. Genetics 176, 2381–2392 (2007). · DOI
- Majiduddin, F. K. & Palzkill, T. Amino acid residues that contribute to substrate specificity of class A beta-lactamase SME-1. Antimicrob. Agents Chemother. 49, 3421–3427 (2005). · DOI
- Bush, K. & Bradford, P. A. Epidemiology of beta-lactamase-producing pathogens. Clin. Microbiol. Rev. 33, e00047–19 (2020). · DOI · Paper page
- Deng, Z. et al. Deep sequencing of systematic combinatorial libraries reveals beta-lactamase sequence constraints at high resolution. J. Mol. Biol. 424, 150–167 (2012). · DOI · Paper page
- Lu, S. et al. Mutagenesis and structural analysis reveal the CTX-M beta-lactamase active site is optimized for cephalosporin catalysis and drug resistance. J. Biol. Chem. 299, 104630 (2023). · doi:10.1016/j.jbc.2023.104630
- Judge, A. et al. Mapping the determinants of catalysis and substrate specificity of the antibiotic resistance enzyme CTX-M beta-lactamase. Commun. Biol. 6, 35 (2023). · DOI
- Judge, A. et al. Network of epistatic interactions in an enzyme active site revealed by large-scale deep mutational scanning. Proc. Natl Acad. Sci. USA 121, e2313513121 (2024). · DOI · Paper page
- Jacquier, H. et al. Capturing the mutational landscape of the beta-lactamase TEM-1. Proc. Natl Acad. Sci. USA 110, 13067–13072 (2013). · DOI · Paper page
- Linkevicius, M., Sandegren, L. & Andersson, D. I. Potential of tetracycline resistance proteins to evolve tigecycline resistance. Antimicrob. Agents Chemother. 60, 789–796 (2016). · DOI · Paper page
- Novais, A. et al. Evolutionary trajectories of beta-lactamase CTX-M-1 cluster enzymes: predicting antibiotic resistance. PLoS Pathog. 6, e1000735 (2010). · DOI
- Lutz, R. & Bujard, H. Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements. Nucleic Acids Res. 25, 1203–1210 (1997). · DOI · Paper page
- Huerta-Cepas, J., Serra, F. & Bork, P. ETE 3: reconstruction, analysis, and visualization of phylogenomic data. Mol. Biol. Evol. 33, 1635–1638 (2016). · DOI · Paper page
- Sohngen, C., Bunk, B., Podstawka, A., Gleim, D. & Overmann, J. BacDive-the bacterial diversity metadatabase. Nucleic Acids Res 42, D592–D599 (2014). · doi:10.1093/nar/gkt1058
- CLSI. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 12th edition (Clinical and Laboratory Standards Institute, 2018).
- Feldgarden, M. et al. AMRFinderPlus and the Reference Gene Catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulence. Sci. Rep. 11, 12728 (2021). · DOI · Paper page
- Seemann, T. Prokka: rapid prokaryotic genome annotation. Bioinformatics 30, 2068–2069 (2014). · DOI · Paper page
Cited by
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Metadata
- Authors
- Blake, K. S., Xue, Y.-P., Gillespie, V. J., Fishbein, S. R. S., Tolia, N. H., Wencewicz, T. A., & Dantas, G.
- Venue
- Nature Communications
- Published
- 2025-02-07
- Volume
- 16
- Issue
- 1
- ISSN
- 2041-1723
- Cited by
- 80
- References
- 12
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Funders
- U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (T32-DK007130)
- U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (2U01AI123394)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The tetracycline resistome is shaped by selection for specific resistance mechanisms by each antibiotic generation. https://app.cochat.ai/papers/10.1038/s41467-025-56425-5
- The paper
- Blake, K. S., Xue, Y.-P., Gillespie, V. J., Fishbein, S. R. S., Tolia, N. H., Wencewicz, T. A., & Dantas, G. (2025). The tetracycline resistome is shaped by selection for specific resistance mechanisms by each antibiotic generation. Nature Communications. https://doi.org/10.1038/s41467-025-56425-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.